ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,012.28
-1.46%
US Tech 100
20,580.00
-2.86%
다우존스 지수
44,713.58
0.65%
Bitcoin
101,842.67
-0.22%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. MannKind Corporation (MNKD)

  7. MannKind Corporation (MNKD) 뉴스

MNKD

MannKind (MNKD)

MannKind Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MNKD
일자시간출처헤드라인심볼기업
2025/01/0707:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
2025/01/0706:30GlobeNewswire Inc.MannKind Expands Executive Leadership TeamNASDAQ:MNKDMannKind Corporation
2024/12/1821:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
2024/12/1821:00GlobeNewswire Inc.MannKind Corporation Announces Exchange of Convertible Notes for Stock and CashNASDAQ:MNKDMannKind Corporation
2024/12/1620:05GlobeNewswire Inc.MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)NASDAQ:MNKDMannKind Corporation
2024/12/1120:00GlobeNewswire Inc.CDSCO Approves Afrezza® (insulin human) Inhalation Powder in IndiaNASDAQ:MNKDMannKind Corporation
2024/11/2611:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/2306:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/2011:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/1606:01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/0911:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/0806:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNKDMannKind Corporation
2024/11/0806:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
2024/11/0806:02GlobeNewswire Inc.MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business UpdateNASDAQ:MNKDMannKind Corporation
2024/11/0706:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/0606:15GlobeNewswire Inc.MannKind to Present at 2024 UBS Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
2024/11/0511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/11/0420:05GlobeNewswire Inc.MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic DiseasesNASDAQ:MNKDMannKind Corporation
2024/11/0105:05GlobeNewswire Inc.MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024NASDAQ:MNKDMannKind Corporation
2024/09/3019:00GlobeNewswire Inc.More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)NASDAQ:MNKDMannKind Corporation
2024/09/1819:15GlobeNewswire Inc.MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
2024/09/1105:30GlobeNewswire Inc.MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
2024/09/0510:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/09/0405:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
2024/08/3105:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
2024/08/3010:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/08/3010:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/08/3010:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/08/3010:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
2024/08/3006:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
 검색 관련기사 보기:NASDAQ:MNKD

최근 히스토리

USI
USTECH100
US Tech 100
FX
USDGBP
US Dollar vs Sterling
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NASDAQ
MSFT
Microsoft
CCOM
US500
US 500
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
COIN
DOGEUSD
Dogecoin
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
COIN
XRPUSD
Ripple
NYSE
NKE
Nike
NYSE
AXP
American Express
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유